ArticleBreast cancer research : BCR2009

Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer.

Ruben Rene Gonzalez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.